Browse medicines, page 9 of 10
Some records contain detailed evidence; others currently contain only basic identity and regulatory information. Reviewed conclusions appear only when they are available for a specific use and group of people.
Medicine type
Approval status
AllApproved in the United States (FDA)Approved in the European Union (EMA)In Phase 3 testingIn Phase 2 testingUsed in a way not covered by an approval, or made by a compounding pharmacyDietary supplement; not FDA-approved as a medicineFDA accelerated approval (based on an earlier result expected to predict benefit; follow-up evidence may be required)Laboratory or animal-stage researchControlled substance; no approved US useWithdrawn from the market
Amount of information
Showing 481–540 of 546 records
Tisotumab Vedotin (Tivdak)
Protein medicineLaboratory or animal-stage researchExpanded recordUse listed on the medicine record
Recurrent or metastatic cervical cancer with disease progression on or after chemotherapy
Tisotumab Vedotin-Tftv (Tivdak)
Protein medicineApproved in the United States (FDA)Expanded recordTrastuzumab Deruxtecan (Enhertu)
Protein medicineLaboratory or animal-stage researchExpanded recordUse listed on the medicine record
Unresectable or metastatic HER2-positive (IHC 3+ or ISH+) breast cancer who have received a prior anti-HER2-based regime
Trastuzumab Emtansine (Kadcyla)
Protein medicineLaboratory or animal-stage researchExpanded recordUse listed on the medicine record
HER2-positive, metastatic breast cancer who previously received trastuzumab and a taxane, separately
Trastuzumab-Pkrb (Herzuma)
Protein medicineApproved in the United States (FDA)Expanded recordUrokinase (Kinlytic)
Protein medicineApproved in the United States (FDA)Expanded recordUstekinumab-Aauz (Otulfi)
Protein medicineApproved in the United States (FDA)Expanded recordVaccinia Virus Modified Strain Ankara-Bavarian Nordic Non-Replicating Antigen (Jynneos)
Protein medicineLaboratory or animal-stage researchExpanded recordVelaglucerase alfa (Vpriv)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
Long-term enzyme replacement therapy
Mirvetuximab Soravtansine-Gynx (Elahere)
Protein medicineApproved in the United States (FDA)Expanded recordNarsoplimab-Wuug (Yartemlea)
Protein medicineApproved in the United States (FDA)Expanded recordNirsevimab-Alip (Beyfortus)
Protein medicineApproved in the United States (FDA)Expanded recordNogapendekin alfa Inbakicept-Pmln (Anktiva)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
BCG-unresponsive nonmuscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or without papillary tumors
Pegfilgrastim-Jmdb (Fulphila)
Protein medicineApproved in the United States (FDA)Expanded recordPeginterferon Beta-1a (Plegridy)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
PLEGRIDY is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. PLEGRIDY is an interferon beta indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults ( 1 )
Pegzilarginase-Nbln (Loargys)
Protein medicineApproved in the United States (FDA)Expanded recordPenpulimab-Kcqx
Protein medicineApproved in the United States (FDA)Expanded recordPrabotulinumtoxina-Xvfs (Jeuveau)
Protein medicineApproved in the United States (FDA)Expanded recordRanibizumab-Eqrn (Cimerli)
Protein medicineApproved in the United States (FDA)Expanded recordRanibizumab-Nuna (Byooviz)
Protein medicineApproved in the United States (FDA)Expanded recordRetifanlimab-Dlwr (Zynyz)
Protein medicineApproved in the United States (FDA)Expanded recordRituximab-Abbs (Truxima)
Protein medicineApproved in the United States (FDA)Expanded recordRituximab-Pvvr (Ruxience)
Protein medicineApproved in the United States (FDA)Expanded recordRubella Virus Strain Wistar Ra 27/3 Live Antigen (M-M-R II / Proquad)
Protein medicineLaboratory or animal-stage researchExpanded recordSebelipase alfa (Kanuma)
Protein medicineApproved in the United States (FDA)Expanded recordStreptococcus Pneumoniae Type 11a Capsular Polysaccharide Antigen (Pneumovax 23)
Protein medicineLaboratory or animal-stage researchExpanded recordStreptococcus Pneumoniae Type 19f Capsular Polysaccharide Antigen (Pneumovax 23)
Protein medicineLaboratory or animal-stage researchExpanded recordStreptococcus Pneumoniae Type 4 Capsular Polysaccharide Diphtheria Crm197 Protein Conjugate Antigen (Vaxneuvance / Prevnar 13 / Prevnar 20)
Protein medicineLaboratory or animal-stage researchExpanded recordStreptococcus Pneumoniae Type 8 Capsular Polysaccharide Antigen (Pneumovax 23)
Protein medicineLaboratory or animal-stage researchExpanded recordTafasitamab-Cxix (Monjuvi)
Protein medicineApproved in the United States (FDA)Expanded recordTalquetamab-Tgvs (Talvey)
Protein medicineApproved in the United States (FDA)Expanded recordTechnetium Tc99m Albumin Aggregated (Pulmotech Maa)
Protein medicineApproved in the United States (FDA)Expanded recordTeprotumumab-Trbw (Tepezza)
Protein medicineApproved in the United States (FDA)Expanded recordTezepelumab-Ekko (Tezspire)
Protein medicineApproved in the United States (FDA)Expanded recordTislelizumab-Jsgr (Tevimbra)
Protein medicineApproved in the United States (FDA)Expanded recordTocilizumab-Aazg (Tyenne)
Protein medicineApproved in the United States (FDA)Expanded recordTocilizumab-Anoh (Avtozma)
Protein medicineApproved in the United States (FDA)Expanded recordTrastuzumab-Anns (Kanjinti)
Protein medicineApproved in the United States (FDA)Expanded recordTrastuzumab-Dkst (Ogivri)
Protein medicineApproved in the United States (FDA)Expanded recordTrastuzumab-Dttb (Ontruzant)
Protein medicineApproved in the United States (FDA)Expanded recordTrastuzumab-Strf (Hercessi)
Protein medicineApproved in the United States (FDA)Expanded recordUblituximab-Xiiy (Briumvi)
Protein medicineApproved in the United States (FDA)Expanded recordUrofollitropin (Bravelle / Fertinex / Metrodin)
Protein medicineApproved in the United States (FDA)Expanded recordUstekinumab-Aekn (Selarsdi)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
Adults and pediatric patients 6 years of age and older with moderate to severe plaque psoriasis who are candidates for phototherapy or syste
Ustekinumab-Auub (Wezlana)
Protein medicineApproved in the United States (FDA)Expanded recordUstekinumab-Hmny (Starjemza)
Protein medicineApproved in the United States (FDA)Expanded recordUstekinumab-Stba (Steqeyma)
Protein medicineApproved in the United States (FDA)Expanded recordUstekinumab-Ttwe (Pyzchiva)
Protein medicineApproved in the United States (FDA)Expanded recordVeligrotug-Vvze (Lumvoa)
Protein medicineApproved in the United States (FDA)Expanded recordVestronidase alfa (Mepsevii)
Protein medicineLaboratory or animal-stage researchExpanded recordUse listed on the medicine record
Mucopolysaccharidosis VII
Vestronidase Alfa-Vjbk (Mepsevii)
Protein medicineApproved in the United States (FDA)Expanded recordZanidatamab-Hrii (Ziihera)
Protein medicineApproved in the United States (FDA)Expanded recordZenocutuzumab-Zbco (Bizengri)
Protein medicineApproved in the United States (FDA)Expanded recordRanibizumab-Leyk (Nufymco)
Protein medicineApproved in the United States (FDA)Expanded recordRisankizumab-Rzaa (Skyrizi)
Protein medicineApproved in the United States (FDA)Expanded recordStreptococcus Pneumoniae Type 3 Capsular Polysaccharide Diphtheria Crm197 Protein Conjugate Antigen (Vaxneuvance / Capvaxive / Prevnar 13 / Prevnar 20)
Protein medicineLaboratory or animal-stage researchExpanded recordStreptococcus Pneumoniae Type 5 Capsular Polysaccharide Diphtheria Crm197 Protein Conjugate Antigen (Vaxneuvance / Prevnar 13 / Prevnar 20)
Protein medicineLaboratory or animal-stage researchExpanded recordTagraxofusp-Erzs (Elzonris)
Protein medicineApproved in the United States (FDA)Expanded recordTividenofusp Alfa-Eknm (Avlayah)
Protein medicineApproved in the United States (FDA)Expanded recordTrastuzumab-Qyyp (Trazimera)
Protein medicineApproved in the United States (FDA)Expanded record